
Curis CRIS
$ 0.6
13.21%
Country |
|
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
13.2 M |
Market Cap[1] |
$ 7.9 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
0.01249 |
P/S (LTM) |
0.627323 |
EPS (LTM) |
36.03 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BioNTech SE
BNTX
|
$ 83.55 | -1.55 % | $ 20.2 B | Nasdaq Global Select Market | ||
|
Cue Biopharma
CUE
|
$ 4.71 | 66.27 % | $ 446 M | Nasdaq Capital Market,SPB | ||
|
AIM ImmunoTech
AIM
|
$ 0.13 | -3.75 % | $ 210 K | NYSE American | ||
|
AC Immune SA
ACIU
|
$ 2.11 | -0.24 % | $ 213 M | Nasdaq Global Market | ||
|
DBV Technologies S.A.
DBVT
|
$ 9.71 | -2.8 % | $ 1.36 B | Nasdaq Global Select Market | ||
|
Allogene Therapeutics
ALLO
|
$ 0.7 | -6.1 % | $ 154 M | Nasdaq Global Select Market,SPB | ||
|
Altimmune
ALT
|
$ 1.38 | -9.8 % | $ 122 M | Nasdaq Global Market | ||
|
AnaptysBio
ANAB
|
$ 46.44 | 1.82 % | $ 1.35 B | Nasdaq Global Select Market,SPB | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | ||
|
Ascendis Pharma A/S
ASND
|
$ 270.27 | -0.34 % | $ 16.4 B | Nasdaq Global Select Market | ||
|
Precision BioSciences
DTIL
|
$ 7.1 | 0.64 % | $ 91.1 M | Nasdaq Global Select Market | ||
|
Arcturus Therapeutics Holdings
ARCT
|
$ 8.03 | 0.75 % | $ 220 M | Nasdaq Global Market,SPB | ||
|
Aurinia Pharmaceuticals
AUPH
|
$ 15.13 | -1.79 % | $ 2.03 B | Nasdaq Global Market | ||
|
Autolus Therapeutics plc
AUTL
|
$ 1.07 | -2.29 % | $ 285 M | Nasdaq Global Select Market | ||
|
Atea Pharmaceuticals
AVIR
|
$ 3.99 | 0.71 % | $ 325 M | Nasdaq Global Select Market | ||
|
Exelixis
EXEL
|
$ 68.26 | -0.35 % | $ 18.5 B | Nasdaq Global Select Market,SPB | ||
|
Axsome Therapeutics
AXSM
|
$ 133.97 | -1.46 % | $ 6.66 B | Nasdaq Global Market,SPB | ||
|
BridgeBio Pharma
BBIO
|
$ 77.98 | 1.54 % | $ 14.9 B | Nasdaq Global Select Market,SPB | ||
|
BioCryst Pharmaceuticals
BCRX
|
$ 7.31 | -2.6 % | $ 1.53 B | Nasdaq Global Select Market | ||
|
Bicycle Therapeutics plc
BCYC
|
$ 3.1 | -3.13 % | $ 215 M | Nasdaq Global Select Market | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
$ 4.64 | 17.17 % | $ 56.6 M | Nasdaq Capital Market | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 12.93 | -2.34 % | $ 836 M | NYSE | ||
|
InMed Pharmaceuticals
INM
|
$ 15.56 | 13.57 % | $ 64.8 M | Nasdaq Capital Market | ||
|
Immutep Limited
IMMP
|
$ 3.29 | 0.92 % | $ 4.79 B | Nasdaq Global Market | ||
|
BeyondSpring
BYSI
|
$ 0.46 | -18.4 % | $ 18.9 M | Nasdaq Capital Market | ||
|
Cabaletta Bio
CABA
|
$ 1.06 | 3.43 % | $ 107 M | Nasdaq Global Select Market | ||
|
C4 Therapeutics
CCCC
|
$ 2.48 | -2.17 % | $ 206 M | Nasdaq Global Select Market | ||
|
Coherus BioSciences
CHRS
|
$ 0.41 | -14.71 % | $ 48 M | Nasdaq Global Market | ||
|
Celldex Therapeutics
CLDX
|
$ 27.63 | -1.46 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
Cellectis S.A.
CLLS
|
$ 1.02 | -3.42 % | $ 102 M | Nasdaq Global Market | ||
|
Armata Pharmaceuticals
ARMP
|
$ 3.13 | 17.67 % | $ 113 M | NYSE American | ||
|
Edesa Biotech
EDSA
|
$ 2.07 | 5.61 % | $ 11.8 M | Nasdaq Capital Market | ||
|
Collegium Pharmaceutical
COLL
|
$ 26.02 | 1.84 % | $ 824 M | Nasdaq Global Select Market | ||
|
GlaxoSmithKline plc
GSK
|
$ 48.61 | -1.28 % | $ 197 B | NYSE | ||
|
CorMedix
CRMD
|
$ 4.51 | -3.53 % | $ 325 K | Nasdaq Global Market | ||
|
CRISPR Therapeutics AG
CRSP
|
$ 40.19 | 0.09 % | $ 3.61 B | Nasdaq Global Market,SPB | ||
|
Forte Biosciences
FBRX
|
$ 76.99 | 0.03 % | $ 997 M | Nasdaq Capital Market | ||
|
Champions Oncology
CSBR
|
$ 4.59 | 0.04 % | $ 63.5 M | Nasdaq Capital Market | ||
|
Fennec Pharmaceuticals
FENC
|
$ 13.29 | -2.14 % | $ 380 M | Nasdaq Capital Market | ||
|
Cytokinetics, Incorporated
CYTK
|
$ 51.27 | -0.74 % | $ 6.16 M | Nasdaq Global Select Market,SPB | ||
|
Immunome
IMNM
|
$ 16.67 | -2.97 % | $ 1.46 B | Nasdaq Global Select Market | ||
|
Immunic
IMUX
|
$ 7.53 | 2.73 % | $ 1.17 B | Nasdaq Global Select Market | ||
|
Immunovant
IMVT
|
$ 33.18 | -0.09 % | $ 6.05 B | Nasdaq Global Select Market | ||
|
Incyte Corporation
INCY
|
$ 117.79 | -1.09 % | $ 23 B | Nasdaq Global Select Market,SPB | ||
|
Insmed Incorporated
INSM
|
$ 120.17 | -1.39 % | $ 23.9 B | Nasdaq Global Select Market | ||
|
Iovance Biotherapeutics
IOVA
|
$ 7.49 | -0.6 % | $ 2.68 M | Nasdaq Global Market,SPB | ||
|
Dyadic International
DYAI
|
$ 0.32 | 1.27 % | $ 11.6 M | Nasdaq Capital Market | ||
|
Ironwood Pharmaceuticals
IRWD
|
$ 4.79 | -1.75 % | $ 775 M | Nasdaq Global Select Market | ||
|
Fulcrum Therapeutics
FULC
|
$ 3.73 | -0.67 % | $ 284 M | Nasdaq Global Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.